ANI Pharmaceuticals
ANIP
67 hedge funds and large institutions have $118M invested in ANI Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 6 closing their positions.
583% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 6
358% more capital invested
Capital invested by funds: $25.8M → $118M (+$92.4M)
109% more funds holding
Funds holding: 32 → 67 (+35)
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$12.1M |
| 2 |
DM
Deerfield Management
New York
|
+$9.86M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$6.67M |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$6.63M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$4.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
-$9.34M |
| 2 |
MOACM
Mutual of America Capital Management
New York
|
-$1.22M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$997K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$227K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
-$127K |
ANIP Hedge Fund Activity: Q1 2014 in Review
67 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q1 2014, worth a combined $118M — up 358% from $25.8M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new ANIP positions and 6 closed out — a net gain of 35 holders — while 12 added to existing stakes and 6 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $12.1M. The largest seller was Healthcare Value Capital, cutting an estimated $9.34M.
- 67 institutional investors held ANI Pharmaceuticals (ANIP) as of Q1 2014, up from 32 in Q4 2013.
- Funds reported $118M of ANI Pharmaceuticals stock for Q1 2014, up 358% quarter-over-quarter.
- 41 funds opened new ANI Pharmaceuticals positions in Q1 2014 and 6 closed out, a net change of +35 holders.
- The largest ANI Pharmaceuticals buyer in Q1 2014 was Millennium Management, an estimated $12.1M added.
- The largest ANI Pharmaceuticals seller in Q1 2014 was Healthcare Value Capital, an estimated $9.34M sold.
Based on aggregated 13F filings for Q1 2014.